Literature DB >> 24136829

Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions: findings on MRI and computed tomography imaging.

Kefu Liu1, Ping Xie, Weijun Peng, Zhengrong Zhou.   

Abstract

PURPOSE: To retrospectively analyze MRI and computed tomographic (CT) findings from renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions (Xp11-RCC).
MATERIALS AND METHODS: Institutional review board permission was obtained to review patient medical records, and the requirement for informed consent was waved . The clinical and MRI/CT features of five cases with Xp11-RCC that were confirmed by pathology were analyzed retrospectively. The image characteristics included the lesion location and size, contribution of cystic and solid components, intratumoral necrosis or hemorrhage, invasion of perinephric tissue and renal sinus, lymphadenopathy, major venous or arterial vascular invasion, pattern of the tumor growth, intratumor calcification and lipids, homogeneity of SI on T2-weighted images, attenuation and SI of the mass with respect to the normal renal cortex on precontrast and contrasted CT/MRI images, tumor SIs, tumor attenuations and tumor-to-cortex indices, homogeneity of enhancement on the contrasted images.
RESULTS: The mean age was 32 years (range, 15-47 years). Most patients (4/5) were women. All tumors showed a cortical location. The average tumor size was 9 cm (range, 4-18 cm). Four tumors comprised a predominantly solid lesion with focal necrosis, and one tumor comprised a solid lesion with significant necrosis. All tumors showed intertumor hemorrhage, infiltrative growth and invasion of the perirenal adipose/renal sinus. Four cases showed retroperitoneal lymphadenopathy, of which one case showed simultaneous mediastinal and supraclavicular lymphadenopathy. All tumors from four cases showed mild hyperintensity on T1-weighted MRI images, and three tumors showed hypointensity on T2-weighted MRI images relative to the renal cortex except for 1 tumor that showed significant hemorrhage and a relative hyperintensity. For 3 cases who were imaged with CT, two tumors imaged using nonenhanced CT images showed mild hyperdensity relative to the renal cortex. Calcification was noted in all three tumors. All tumors showed mild, persistent enhancement.
CONCLUSION: Typical Xp11-RCC manifests as an advanced, solid renal mass with mild persistent enhancement, a prevalence of intertumor hemorrhage/calcification, and a cortical epicenter location. The predilection for children and young adults is a useful clinical feature when confirming a diagnosis of Xp11-RCC.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  CT; MRI; TFE3 gene fusion; Xp11.2 translocation; renal cell carcinoma

Mesh:

Substances:

Year:  2013        PMID: 24136829     DOI: 10.1002/jmri.24349

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  11 in total

1.  Xp11.2 translocation renal cell carcinoma with egg-shell calcification mimicking a benign renal tumour: A case report.

Authors:  Wenjie Liang; Shunliang Xu
Journal:  Oncol Lett       Date:  2015-09-17       Impact factor: 2.967

2.  Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion: A case report.

Authors:  Xiang Pan; Jing Quan; Liwen Zhao; Wenhua Li; Benlin Wei; Shangqi Yang; Yongqing Lai
Journal:  Mol Clin Oncol       Date:  2017-11-13

Review 3.  Renal Tumors of Childhood: Radiologic-Pathologic Correlation Part 2. The 2nd Decade: From the Radiologic Pathology Archives.

Authors:  Ellen M Chung; Grant E Lattin; Kimberly E Fagen; Andrew M Kim; Michael A Pavio; Adam J Fehringer; Richard M Conran
Journal:  Radiographics       Date:  2017 Sep-Oct       Impact factor: 5.333

4.  Renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion: imaging findings in 21 patients.

Authors:  Xiao Chen; Qingqiang Zhu; Baoxin Li; Wenjing Cui; Hao Zhou; Na Duan; Yongkang Liu; Vikas Kundra; Zhongqiu Wang
Journal:  Eur Radiol       Date:  2016-06-02       Impact factor: 5.315

Review 5.  MRI phenotype in renal cancer: is it clinically relevant?

Authors:  Naomi Campbell; Andrew B Rosenkrantz; Ivan Pedrosa
Journal:  Top Magn Reson Imaging       Date:  2014-04

Review 6.  Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies.

Authors:  Xiangming Cheng; Weidong Gan; Gutian Zhang; Xiaogong Li; Hongqian Guo
Journal:  BMC Urol       Date:  2016-07-11       Impact factor: 2.264

7.  Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas.

Authors:  Jian He; Kefeng Zhou; Bin Zhu; Gutian Zhang; Xiaogong Li; Hongqian Guo; Weidong Gan; Zhengyang Zhou; Tian Liu
Journal:  Biomed Res Int       Date:  2015-11-09       Impact factor: 3.411

8.  MiT translocation renal cell carcinomas: two subgroups of tumours with translocations involving 6p21 [t (6; 11)] and Xp11.2 [t (X;1 or X or 17)].

Authors:  Milan Hora; Tomáš Urge; Ivan Trávníček; Jiří Ferda; Zdeněk Chudáček; Tomáš Vaněček; Michal Michal; Fredrik Petersson; Naoto Kuroda; Ondřej Hes
Journal:  Springerplus       Date:  2014-05-13

9.  Ultrasonographic Findings of Renal Cell Carcinomas Associated with Xp11.2 Translocation/TFE3 Gene Fusion.

Authors:  Wenwu Ling; Xuelei Ma; Yan Luo; Linyan Chen; Huiyao Wang; Xiaoling Wang; Ni Chen; Hao Zeng; Yongzhong Li; Diming Cai
Journal:  Contrast Media Mol Imaging       Date:  2017-11-23       Impact factor: 3.161

Review 10.  Adult-onset renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: 3 case reports and review of literature.

Authors:  Pengfeng Gong; Qianfeng Zhuang; Kun Wang; Renfang Xu; Yiming Chen; Xiaogang Wang; Shuai Yin
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.